These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 24554659)

  • 21. A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.
    Bonavia A; Bullock BT; Gisselman KM; Margulies BJ; Clements JE
    Virology; 2005 Oct; 341(1):12-23. PubMed ID: 16061266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
    Igarashi T; Donau OK; Imamichi H; Dumaurier MJ; Sadjadpour R; Plishka RJ; Buckler-White A; Buckler C; Suffredini AF; Lane HC; Moore JP; Martin MA
    J Virol; 2003 Dec; 77(24):13042-52. PubMed ID: 14645561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission.
    Gonzalez MW; DeVico AL; Lewis GK; Spouge JL
    J Virol; 2015 Apr; 89(7):3619-29. PubMed ID: 25589663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-protective immune responses induced in rhesus macaques by immunization with attenuated macrophage-tropic simian immunodeficiency virus.
    Clements JE; Montelaro RC; Zink MC; Amedee AM; Miller S; Trichel AM; Jagerski B; Hauer D; Martin LN; Bohm RP
    J Virol; 1995 May; 69(5):2737-44. PubMed ID: 7707496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T Cell-Macrophage Fusion Triggers Multinucleated Giant Cell Formation for HIV-1 Spreading.
    Bracq L; Xie M; Lambelé M; Vu LT; Matz J; Schmitt A; Delon J; Zhou P; Randriamampita C; Bouchet J; Benichou S
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The SIV Envelope Glycoprotein, Viral Tropism, and Pathogenesis: Novel Insights from Nonhuman Primate Models of AIDS.
    Swanstrom AE; Del Prete GQ; Deleage C; Elser SE; Lackner AA; Hoxie JA
    Curr HIV Res; 2018; 16(1):29-40. PubMed ID: 29173176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The emergence and characterization of macrophage-tropic SIV/HIV chimeric viruses (SHIVs) present in CD4+ T cell-depleted rhesus monkeys.
    Igarashi T; Imamichi H; Brown CR; Hirsch VM; Martin MA
    J Leukoc Biol; 2003 Nov; 74(5):772-80. PubMed ID: 14595005
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The proteins of lymphocyte- and macrophage-tropic strains of simian immunodeficiency virus are processed differently in macrophages.
    Stephens EB; McClure HM; Narayan O
    Virology; 1995 Jan; 206(1):535-44. PubMed ID: 7831808
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV
    von Bredow B; Andrabi R; Grunst M; Grandea AG; Le K; Song G; Berndsen ZT; Porter K; Pallesen J; Ward AB; Burton DR; Evans DT
    mBio; 2019 Jul; 10(4):. PubMed ID: 31266872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced macrophage tropism of HIV in brain and lymphoid tissues is associated with sensitivity to the broadly neutralizing CD4 binding site antibody b12.
    Dunfee RL; Thomas ER; Gabuzda D
    Retrovirology; 2009 Jul; 6():69. PubMed ID: 19619305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutralization/enhancement of macrophage-tropic SIVmac infection by plasma from macaques infected with macrophage-tropic or lymphocyte-tropic SIVmac.
    Jolly PE; Huang L; Chen S
    Cell Mol Biol (Noisy-le-grand); 2001 Sep; 47(6):997-1008. PubMed ID: 11785666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A replication-competent, neutralization-sensitive variant of simian immunodeficiency virus lacking 100 amino acids of envelope.
    Johnson WE; Morgan J; Reitter J; Puffer BA; Czajak S; Doms RW; Desrosiers RC
    J Virol; 2002 Mar; 76(5):2075-86. PubMed ID: 11836385
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stoichiometry for entry and binding properties of the Env protein of R5 T cell-tropic HIV-1 and its evolutionary variant of macrophage-tropic HIV-1.
    Bonner X; Sondgeroth A; McCue A; Nicely N; Tripathy A; Spielvogel E; Moeser M; Ke R; Leiderman K; Joseph SB; Swanstrom R
    mBio; 2024 Apr; 15(4):e0032124. PubMed ID: 38426750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential utilization of CCR5 by macrophage and T cell tropic simian immunodeficiency virus strains.
    Edinger AL; Amedee A; Miller K; Doranz BJ; Endres M; Sharron M; Samson M; Lu ZH; Clements JE; Murphey-Corb M; Peiper SC; Parmentier M; Broder CC; Doms RW
    Proc Natl Acad Sci U S A; 1997 Apr; 94(8):4005-10. PubMed ID: 9108095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages.
    Musich T; O'Connell O; Gonzalez-Perez MP; Derdeyn CA; Peters PJ; Clapham PR
    Retrovirology; 2015 Mar; 12():25. PubMed ID: 25809903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.
    Johnson WE; Sanford H; Schwall L; Burton DR; Parren PW; Robinson JE; Desrosiers RC
    J Virol; 2003 Sep; 77(18):9993-10003. PubMed ID: 12941910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
    J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
    Ly A; Stamatatos L
    J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms for adaptation of simian immunodeficiency virus to replication in alveolar macrophages.
    Mori K; Rosenzweig M; Desrosiers RC
    J Virol; 2000 Nov; 74(22):10852-9. PubMed ID: 11044136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of entry phenotypes of macrophage-tropic HIV-1 across a wide range of CD4 densities.
    Joseph SB; Arrildt KT; Swanstrom AE; Schnell G; Lee B; Hoxie JA; Swanstrom R
    J Virol; 2014 Feb; 88(4):1858-69. PubMed ID: 24307580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.